Home

OGI

Organigram Global Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$1.36

-1.45%

2026-05-08

About Organigram Global Inc.

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.

Key Fundamentals

P/E Ratio

12.55

Forward P/E

57.50

EPS (TTM)

$0.11

ROE

4.6%

Revenue Growth (YoY)

48.7%

Profit Margin

6.5%

Debt/Equity

1.99

Price/Book

0.69

Beta

1.91

Market Cap

$194.1M

Avg Volume (10D)

740K

Recent Breakout Signals

No recent breakout signals detected for OGI.

Recent Price Range (60 Days)

60D High

$1.66

60D Low

$1.24

Avg Volume

649K

Latest Close

$1.36

Get breakout alerts for OGI

Sign up for Breakout Scanner to receive daily notifications when OGI triggers breakout signals. Build custom AI screeners and backtest strategies.

Start Free Trial

7-day free trial. No card required.

Organigram Global Inc. (OGI) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors OGI daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. OGI operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.